Avenir Wellness Solutions Inc (AVRW)
0.0539
0.00 (0.00%)
USD |
OTCM |
Jun 14, 16:00
Avenir Wellness Solutions Enterprise Value: 12.82M for June 14, 2024
Enterprise Value Chart
Historical Enterprise Value Data
| Date | Value |
|---|---|
| June 14, 2024 | 12.82M |
| June 13, 2024 | 12.51M |
| June 12, 2024 | 12.15M |
| June 11, 2024 | 12.15M |
| June 10, 2024 | 12.15M |
| June 07, 2024 | 12.51M |
| June 06, 2024 | 12.43M |
| June 05, 2024 | 11.89M |
| June 04, 2024 | 11.11M |
| June 03, 2024 | 12.43M |
| May 31, 2024 | 11.65M |
| May 30, 2024 | 11.65M |
| May 29, 2024 | 11.65M |
| May 28, 2024 | 11.66M |
| May 24, 2024 | 11.66M |
| May 23, 2024 | 11.66M |
| May 22, 2024 | 11.65M |
| May 21, 2024 | 11.11M |
| May 20, 2024 | 11.50M |
| May 17, 2024 | 12.04M |
| May 16, 2024 | 11.64M |
| May 15, 2024 | 11.64M |
| May 14, 2024 | 11.20M |
| May 13, 2024 | 11.20M |
| May 10, 2024 | 11.20M |
| Date | Value |
|---|---|
| May 09, 2024 | 11.20M |
| May 08, 2024 | 11.47M |
| May 07, 2024 | 11.47M |
| May 06, 2024 | 11.20M |
| May 03, 2024 | 11.66M |
| May 02, 2024 | 11.19M |
| May 01, 2024 | 11.19M |
| April 30, 2024 | 11.64M |
| April 29, 2024 | 12.12M |
| April 26, 2024 | 12.12M |
| April 25, 2024 | 12.51M |
| April 24, 2024 | 11.15M |
| April 23, 2024 | 11.81M |
| April 22, 2024 | 11.81M |
| April 19, 2024 | 11.92M |
| April 18, 2024 | 11.73M |
| April 17, 2024 | 11.11M |
| April 16, 2024 | 11.11M |
| April 15, 2024 | 11.34M |
| April 12, 2024 | 11.46M |
| April 11, 2024 | 11.46M |
| April 10, 2024 | 11.46M |
| April 09, 2024 | 11.68M |
| April 08, 2024 | 11.46M |
| April 05, 2024 | 11.12M |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
10.56M
Minimum
Mar 13 2024
227.89M
Maximum
Jun 26 2019
53.26M
Average
40.69M
Median
Apr 25 2022
Enterprise Value Benchmarks
| NovaBay Pharmaceuticals Inc | 3.382M |
| Palatin Technologies Inc | 19.39M |
| iBio Inc | 30.46M |
| Theriva Biologics Inc | -10.87M |
| Oragenics Inc | 6.996M |
Enterprise Value Related Metrics
| Net Income (Quarterly) | -1.295M |
| Revenue (Quarterly) | 0.44M |
| Total Expenses (Quarterly) | 1.311M |
| EPS Diluted (Quarterly) | -0.02 |
| Gross Profit Margin (Quarterly) | 78.64% |
| Profit Margin (Quarterly) | -294.3% |
| Earnings Yield | -111.3% |
| Normalized Earnings Yield | -125.59 |